Emtricitabine/Tenofovir Disoproxil Tillomed

Emtricitabine/Tenofovir Disoproxil Tillomed is an oral medication used for HIV treatment and prevention. This combination drug helps manage HIV infection and reduce the risk of transmission.

Emtricitabine/Tenofovir Disoproxil Tillomed is primarily used in the treatment of HIV-1 infection in adults and adolescents. It is also used for pre-exposure prophylaxis (PrEP) to prevent HIV infection in individuals at high risk. This medication works by reducing the amount of HIV in the body, helping to control the infection and improve immune function.

Common effects of Emtricitabine/Tenofovir Disoproxil Tillomed may include headache, nausea, diarrhea, and dizziness. Some individuals may experience changes in body fat distribution, such as increased fat in the upper back and neck, or loss of fat in the legs, arms, and face. It is important to discuss any persistent or severe side effects with a healthcare provider.

Emtricitabine/Tenofovir Disoproxil Tillomed should be used with caution in individuals with kidney problems, as the medication is primarily eliminated through the kidneys. Regular monitoring of kidney function is recommended. This medication should not be used by individuals who are allergic to emtricitabine or tenofovir disoproxil fumarate. Pregnant women should consult their healthcare provider before using this medication.

Emtricitabine/Tenofovir Disoproxil Tillomed may interact with other medications, including those used to treat HIV, hepatitis B, and other infections. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated, as it may exacerbate certain side effects.